We Have Done Nearly 2.5 Million RT-PCR Tests So Far: Dr Arvind Lal, Dr Lal PathLabs

Dr Arvind Lal, Executive Chairman, Dr Lal PathLabs and a Padma Shri recipient, in an exclusive conversation with BW Busienssworld’s Jyotsna Sharma, speaks about how the leading diagnostic chain tackled Covid-19, expansion plans and the key focus areas of focus for the healthcare sector

Dr Lal Pathlabs Q1 Net Profit Zooms Nearly 5-Fold To Rs 133.7 Cr

Shares of Dr Lal PathLabs were trading at Rs 3,956.55 per scrip on BSE, up 6 per cent from its previous close.

Diagnostic Business Under COVID Stress

Leading diagnostic chain Dr Lal PathLabs has seen an 80 per cent drop in business, Dr Arvind Lal tells BW Businessworld. Lal was recognized with Padma Shri in 2009, the fourth highest civilian honor, for his contributions to Medicine.

The IPO King

The Initial Public Offering mart is cut-throat; it helps that the managing director & CEO of Kotak Mahindra Capital Company (KMCC) multi-tasks well

2015 Marks Mixed Trend For Pharma Sector

The Rs 1,50,000 crore worth drugs pharmaceuticals industry is currently one of the most robust sectors in India

Striving To Provide Better Diagnostics Services

Facing A Lull After The Storm